Ayurvedic Supplement Body Revival Shows Promise in Phase II Breast Cancer Trial
核心洞察
Body Revival (搜索), an Ayurvedic herbal formulation containing nine traditional herbs, has successfully completed Phase II clinical trials demonstrating significant benefits for breast cancer (搜索) patients undergoing conventional treatment.
The 12-week trial at J.B. Roy State Ayurvedic Medical College involved 44 breast cancer (搜索) patients, showing improvements in quality of life metrics and key blood parameters during chemotherapy and radiation.
The proprietary micro-herbal solution, developed over 25 years of research, combines traditional ingredients like Ashwagandha and Bael (搜索) with modern scientific methodology to address cancer care challenges.
In a significant development for integrative cancer care, Body Revival (搜索), a novel Ayurvedic herbal formulation, has demonstrated promising results in Phase II clinical trials for breast cancer (搜索) patients. The study, conducted at J.B. Roy State Ayurvedic Medical College and Hospital (搜索) in Kolkata, marks an important milestone in bridging traditional medicine with modern oncology practices.
Clinical Trial Results and Impact
The 12-week trial enrolled 44 breast cancer (搜索) patients who were concurrently receiving conventional radiation and chemotherapy treatments. Participants showed notable improvements across multiple parameters, including enhanced emotional and physical well-being. Significant positive changes were observed in key clinical markers, including hemoglobin levels, white blood cell counts, and tumor markers.
The study specifically evaluated the supplement's safety profile and its potential to mitigate treatment-related side effects, with results indicating favorable outcomes in both areas. This data suggests Body Revival (搜索) could serve as a complementary therapy alongside standard cancer treatments.
Product Development and Composition
Body Revival (搜索) represents a culmination of 25 years of research and development, combining traditional Ayurvedic knowledge with modern scientific methodologies. The proprietary micro-herbal solution incorporates nine carefully selected Ayurvedic herbs, including:
- Bael
- Vacha
- Ashwagandha
- Manjishtha
- Honey
Each ingredient was chosen for its documented anti-cancer properties and immune-enhancing capabilities, according to traditional Ayurvedic principles.
Future Directions and Market Implications
Munish Khan, CEO and Director of the company developing Body Revival (搜索), emphasized the significance of these results: "This clinical trial underscores the potential of Ayurveda in modern cancer care. Body Revival represents a shift toward holistic, patient-centric approaches in treatment."
The company has outlined plans to expand their research to include other types of cancer and is preparing for global market entry. This expansion aligns with growing international interest in evidence-based complementary medicine for cancer care.
The development of Body Revival (搜索) has been supported by India's Ministry of AYUSH, reflecting a broader national initiative to validate and modernize traditional medicine approaches. This governmental backing has been instrumental in facilitating rigorous clinical research of Ayurvedic treatments.